BRCA2 and breast carcinoma: Regular use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) has been consistently associated with reduced risk of cancers, including breast cancer [3], and reduced breast cancer risk in high-risk women with BRCA1 and BRCA2 mutations [4].